Back to dashboard
Low impact

Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo) (CPB 0977, reviewed 2026-04-24)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 13, 2026
Days to comply
—

Related policy hubs